普通人群对扩展性携带者筛查的兴趣:系统综述
结果显示,对假想ECS测试的兴趣为32%-76%,而实际ECS接受率为8%-50%;孕妇接受率最高(50%),孕前人群较低(8-34%)。提示意向与实际接受率之间存在差异,尤其在孕前阶段。
要点
- 普通人群对ECS的假想兴趣较高(32%-76%),但实际接受率较低(8%-50%)。
- 孕妇对ECS的实际接受率最高(50%),孕前人群接受率较低(8-34%)。
- 需提供充分的检测前后咨询,以支持夫妇做出知情的生殖决策。
核心结论
- prospective parents对ECS的意向与实际接受率可能存在差异,尤其在孕前阶段。
主要发现
- 对假想ECS测试的兴趣范围为32%-76%,实际ECS接受率范围为8%-50%。
- 孕妇的总体接受率最高(50%),孕前人群的接受率较低(8-34%),但一项孕前咨询准备IVF的研究中女性接受率达68.7%。
临床怎么用
- 应为提供ECS的夫妇提供充分的检测前后咨询,确保知情的生殖决策,并制定初级卫生保健专业人员指南。
局限性
- 由于原始研究的样本和方法限制,部分报告结果可能无法推广至更广泛人群,需更多研究验证趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Through carrier screening, prospective parents can acquire information about whether they have an increased risk of conceiving a child affected with an autosomal recessive or X-linked condition. Within the last decade, advances in genomic technologies have facilitated a shift from condition-directed carrier screening to expanded carrier screening (ECS). Following the introduction of ECS, several studies have been performed to gauge the interest in this new technology among individuals and couples in the general population. OBJECTIVE AND RATIONALE: The aim of this systematic review was to synthesize evidence from empirical studies that assess the interest in ECS among individuals and couples in the general population. As the availability and accessibility of ECS grow, more couples who are a priori not at risk based on their personal or family history will be presented with the choice to accept or decline such an offer. Their attitudes and beliefs, as well as the perceived usefulness of this screening modality, will likely determine whether ECS is to become a widespread reproductive genetic test. SEARCH METHODS: Four databases (Pubmed, Web of Science, CINAHL, Cochrane Library) were systematically searched to identify English language studies performed between January 2009 and January 2019 using the following search terms: carrier screening, carrier testing, attitudes, intention, interest, views, opinions, perspectives and uptake. Studies were eligible for inclusion if they reported on intentions to undergo a (hypothetical) ECS test, uptake of an actual ECS offer or both. Two researchers performed a multistep selection process independently for validation purposes. OUTCOMES: Twelve empirical studies performed between 2015 and 2019 were included for analysis. The studies originated from the USA (n = 6), the Netherlands (n = 3), Belgium (n = 1), Sweden (n = 1) and Australia (n = 1). The sample size of the studies varied from 80 to 1669. In the included studies, 32%-76% of respondents were interested in a (hypothetical) ECS test, while uptake rates for actual ECS offers ranged from 8% to 50%. The highest overall uptake was observed when ECS was offered to pregnant women (50%). By contrast, studies focusing on the preconception population reported lower overall uptake rates (8-34%) with the exception of one study where women were counseled preconception in preparation for IVF (68.7%). WIDER IMPLICATIONS: Our findings suggest that there may be discrepancies between prospective parents' reported intentions to undergo ECS and their actual uptake, particularly during the preconception period. As ECS is a new and relatively unknown test for most future parents, the awareness and comprehension within the general population could be rather limited. Adequate pre- and post-test counseling services should be made available to couples offered ECS to ensure informed reproductive decision-making, together with guidelines for primary health care professionals. Due to restricted nature of the samples and methods of the underlying primary studies, some of the reported results might not be transferable to a broader population. More research is needed to see if the observed trends also apply to a broader and more diverse population.
引用
- Van Steijvoort E, Chokoshvili D, W Cannon J, et al. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature. Hum Reprod Update. 2020. PMID: 32099997. doi:10.1093/humupd/dmaa001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。